Nuclear medicine (NM) utilizes a variety of unsealed radioactive compounds, known as radiopharmaceuticals or radiotracers. Given in small (tracer) quantities, radiopharmaceuticals typically consist of two components: a radionuclide (also known as a radioisotope) and a molecular or cellular carrier; the latter determines the biologic distribution upon administration to a patient. The most common routes of administration in clinical practice are intravenous (IV) and oral.
|Title of host publication||Emergency Radiology|
|Subtitle of host publication||Imaging of Acute Pathologies|
|Number of pages||16|
|State||Published - Oct 1 2013|
ASJC Scopus subject areas
- Medicine (all)
- Biochemistry, Genetics and Molecular Biology (all)